AEON Biopharma AEON
NYSE AEON
$0.24 0.00 (-0.54%)
As of: Oct 22, 2026 · 3:52 PM EDT

AEON Biopharma (AEON) Net Equity Issued and Repurchased (2021 - 2025)

Updated

AEON Biopharma's Net Equity Issued and Repurchased was -$168,000 in Q4 2025, compared with $97,000 a year earlier.

Analysis

AEON Biopharma (AEON) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends

For FY2025, Net Equity Issued and Repurchased at AEON Biopharma came in at $18.35 million.

  • Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -49.0% (FY2021 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $147,000 in FY2024 and $270.48 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 AEON Biopharma 12.07 Mn -8.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -168,000.00
Sep 30, 2025 84,000.00
Jun 30, 2025 84,000.00
Mar 31, 2025 18.35 Mn
Dec 31, 2024 97,000.00
Mar 31, 2023 259.00 Mn
Dec 31, 2021 -100,000.00
Jun 30, 2021 100,000.00
Mar 31, 2021 277.93 Mn
API Access

AEON Biopharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AEON&period=max&api_key=YOUR_API_KEY